Esophageal varices are the most common type of gastroesophageal varices, with a
prevalence of 50% to 60% among patients with cirrhosis, and up to 85% in patients with …

Primary biliary cholangitis (formerly known as primary biliary cirrhosis, PBC) is an
autoimmune liver disease in which a cycle of immune mediated biliary epithelial cell injury …

Background & Aims Approaches to risk stratification for patients with primary biliary cirrhosis
(PBC) are limited, single-center based, and often dichotomous. We aimed to develop and …

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are infrequent
autoimmune cholestatic liver diseases, that disproportionate to their incidence and …

Objective Hepatocellular carcinoma (HCC) is an infrequent yet critical event in primary
biliary cirrhosis (PBC); however, predictive tools remain ill-defined. Our objective was to …

Background & Aims Outcomes in primary biliary cirrhosis (PBC) can be predicted by
biochemical response to ursodeoxycholic acid (UDCA). Such stratification inadequately …

OBJECTIVES: In this era of near universal ursodeoxycholic acid (UDCA) treatment for
primary biliary cholangitis (PBC), progression to cirrhosis still occurs in an important …

BACKGROUND: Baveno-VI guidelines recommend that patients with compensated cirrhosis
with liver stiffness by transient elastography (LSM-TE)< 20 kPa and platelets> 150,000/mm 3 …

Background & Aims Primary biliary cholangitis (PBC) predominantly affects middle-aged
women; there are few data on disease phenotypes and outcomes of PBC in men and …

METHODS: We performed a study on data of 1746 UDCA-treated patients with PBC from 25
centers in Europe, United States, and Canada. The prognostic performance of the risk …